Follow The Filings

TRS TriMas

TriMas earnings company data as of 8:58 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.50 — —
Rev — — —

Insider trades

Open-market buys and sales by TRS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TRS insider trades
  • $73K bought by 2 insiders
  • $206K sold by 1 insider outside a trading plan
  • $675K sold by 1 insider under 10b5-1 plans
  1. Daniel P Tredwell Director
    Buy
    $2,524 64 shares at $39.63 +0.1% to stake
    Traded Aug 12 Filed Aug 14
  2. Herbert K Parker Director
    Planned sale
    $675K 15,000 shares at $45.03 21% of stake
    Traded Jun 30 Filed Jul 1
  3. Daniel P Tredwell Director
    Buy
    $2,522 62 shares at $40.58 +0.1% to stake
    Traded May 13 Filed May 15
  4. Jodi F. Robin General Counsel and Secretary
    Sale
    $206K 5,000 shares at $41.30 13% of stake
    Traded May 5–7 Filed May 7
  5. Daniel P Tredwell Director
    Buy
    $2,354 60 shares at $39.38 +0.1% to stake
    Traded Mar 5 Filed Mar 9
  6. Daniel P Tredwell Director
    Buy
    $2,351 74 shares at $31.94 +0.1% to stake
    Traded Nov 12, 2025 Filed Nov 14, 2025
  7. Jeffrey A Fielkow Director
    Buy
    $63K 2,000 shares at $31.46 +13% to stake
    Traded Nov 11, 2025 Filed Nov 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants and 8 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13D/A —
8-K 5.07
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 2.01,7.01,9.01
8-K 5.02,9.01
10-K
8-K 5.02,9.01
8-K 2.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.